Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
Li Yin(Tianjin Medical University), Zhaoyi Wang(CHI Health Creighton University Medical Center - Bergan Mercy)
Cited by 42
Related Papers
Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
|PLoS ONE|2012|71
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
|PLoS ONE|2014|67
Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity
|Endocrinology|2013|54